Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Centers for Disease Control and Prevention a Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease
Centers for Disease Control and Prevention a Creutzfeldt-Jakob Disease (CJD) Lookback Study:
Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease
Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease
Related Programs
Prevention of Disease, Disability, and Death by Infectious Diseases
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control and Prevention
Estimated Funding: $0
Office: Centers for Disease Control and Prevention
Estimated Funding: $0
Who's Eligible
Obtain Full Opportunity Text:
Not Available
Additional Information of Eligibility:
Eligibility: This award will be a continuation of funds intended only for grantees previously awarded under RFA-CK-14-005: Centers for Disease Control and Prevention A Creutzfeldt-Jakob Disease (CJD) Lookback Study: Assessing the Risk Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease.
Full Opportunity Web Address:
Contact:
Centers for Disease Control and Prevention (CDC)Office of Grant Services (OGS)Technical Information Management Section (TIMS)Phone: 770-488-2700
Agency Email Description:
ogstims@cdc.gov
Agency Email:
ogstims@cdc.gov
Date Posted:
2017-02-08
Application Due Date:
2017-04-14
Archive Date:
2017-05-14
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
